Caspase-9 regulation: an update

C R Johnson1, W D Jarvis

  • 1Dominion Diagnostics, LLC, North Kingstown, RI 02852, USA. charlene.johnson@dominiondiagnostics.com

Insights

Caspase-9 regulation is updated, focusing on how alternative splicing and post-translational modifications control this key apoptosis protease. These mechanisms fine-tune cell death pathways and maintain cellular balance.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Apoptotic cell death is a crucial biological process regulated by proteases.
  • Caspase-9 is a central initiator protease in the intrinsic pathway of apoptosis.
  • Previous reviews detailed caspase-9 processing and activation, necessitating an update on its regulation.

Purpose of the Study:

  • To provide an updated review on the regulation of caspase-9.
  • To comprehensively describe intra- and intermolecular events modulating caspase-9 expression and activity.
  • To emphasize the role of alternative splicing and post-translational modifications in caspase-9 regulation.

Main Methods:

  • Literature review and synthesis of existing research on caspase-9.
  • Analysis of studies detailing protein expression modulation.
  • Examination of research on post-translational modifications impacting caspase-9 activity.

Main Results:

  • Alternative splicing generates functionally divergent caspase-9 isoforms.
  • Post-translational modifications critically regulate caspase-9 activity.
  • Modulated caspase-9 activity impacts the commitment to apoptosis.
  • Regulation of caspase-9 reflects the balance between cytotoxic and cytoprotective influences.

Conclusions:

  • Caspase-9 activity is precisely controlled through complex regulatory mechanisms.
  • Alternative splicing and post-translational events are key regulators of caspase-9 function.
  • Caspase-9 plays a pivotal role in apoptosis and cellular homeostasis maintenance.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...